• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,672.72 1,144.77
( 1.52%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Parenteral Drugs (India) Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524689
INE904D01019
-300.6045095
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PDPL
0
10.11
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Exide Industries consolidated net profit rises 15.19% in the March 2026 quarter
May 04,2026
Net profit of Exide Industries rose 15.19% to Rs 215.25 crore in the quarter ended March 2026 as against Rs 186.87 crore during the previous quarter ended March 2025. Sales rose 9.22% to Rs 4735.13 crore in the quarter ended March 2026 as against Rs 4335.42 crore during the previous quarter ended March 2025.

For the full year,net profit rose 7.44% to Rs 854.19 crore in the year ended March 2026 as against Rs 795.02 crore during the previous year ended March 2025. Sales rose 4.39% to Rs 17995.35 crore in the year ended March 2026 as against Rs 17237.85 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4735.134335.42 9 17995.3517237.85 4
OPM %10.319.87 -10.3910.43 -
PBDT465.83437.16 7 1847.941758.30 5
PBT327.45289.52 13 1259.191175.96 7
NP215.25186.87 15 854.19795.02 7